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The  rapid  (2  min)  nongenomic  effects  of  aldosterone  (ALDO)  and/or  spironolactone  (MR  antagonist),  RU
486 (GR  antagonist),  atrial  natriuretic  peptide  (ANP)  and  dimethyl-BAPTA  (BAPTA)  on  the  intracellular
pH  recovery  rate  (pHirr)  via  NHE1  (basolateral  Na+/H+ exchanger  isoform),  after  the  acid  load  induced
by NH4Cl,  and  on the  cytosolic  free  calcium  concentration  ([Ca2+]i) were  investigated  in  the proximal  S3
segment  isolated  from  rats,  by the probes  BCECF-AM  and  FLUO-4-AM,  respectively.  The basal  pHi was
7.15 ± 0.008  and  the  basal  pHirr  was  0.195  ± 0.012  pH  units/min  (number  of tubules/number  of  tubular
areas  = 16/96).  Our  results  conﬁrmed  the  rapid  biphasic  effect  of  ALDO  on  NHE1:  ALDO  (10−12 M)  increases
the pHirr  to approximately  59% of  control  value,  and  ALDO  (10−6 M)  decreases  it to  approximately  49%.
Spironolactone  did  not  change  these  effects,  but RU 486  inhibited  the  stimulatory  effect  and  maintained
the  inhibitory  effect.  ANP  (10−6 M) or  BAPTA  (5 × 10−5 M)  alone  had  no  signiﬁcant  effect  on NHE1  but
prevented  both  effects  of  ALDO  on this  exchanger.  The  basal  [Ca2+]i was  104 ± 3 nM  (15),  and  ALDO  (10−12
−6 2+Ca ]i or  10 M)  increased  the  basal  [Ca ]i to  approximately  50%  or 124%,  respectively.  RU 486,  ANP  and  BAPTA
decreased  the  [Ca2+]i and  inhibited  the  stimulatory  effect  of  both  doses  of  ALDO.  The results  suggest  the
involvement  of  GR  on  the  nongenomic  effects  of ALDO  and  indicate  a  pHirr-regulating  role  for  [Ca2+]i
that  is mediated  by NHE1,  stimulated/impaired  by ALDO,  and  affected  by  ANP  or BAPTA with  ALDO.  The
observed  nongenomic  hormonal  interaction  in  the  S3 segment  may  represent  a rapid  and  physiologically
relevant  regulatory  mechanism  in the  intact  animal  under  conditions  of volume  alterations.
© 2011 Elsevier Ltd. Open access under the Elsevier OA license.. Introduction
Recently (over the past seven years), the genomic and nonge-
omic effects of ALDO on the Na+/H+ exchanger of the proximal
ubule have been demonstrated [1–4], including a biphasic effect
n this transporter in which low doses stimulate and high doses
nhibit it [5].  The genomic effects (observed with chronic treat-
ent with ALDO) were sensitive to spironolactone and, therefore,
nvolve the binding of this hormone with its classic receptor (MR)
1,3–6].  However, the receptor and the signal transduction cascades
nvolved in the nongenomic modulation of the Na+/H+ exchanger
y ALDO need to be clariﬁed. Studies in several cell types and in
ubular segments indicate that ERK1/2, PKC and [Ca2+]i participate
n this process [5,7–10].
Abbreviations: ALDO, Aldosterone; ANP, atrial natriuretic peptide; BAPTA,
imethyl-BAPTA; pHi, intracellular pH; pHirr, intracellular pH recovery rate; NHE1,
asolateral Na+/H+ exchanger isoform; [Ca2+]i , cytosolic free calcium concentration.
∗ Corresponding author. Tel.: +55 19 3565 4320; fax: +55 19 3565 4117.
E-mail address: leite-dellova@usp.br (D.C.A. Leite-Dellova).
960-0760 © 2011 Elsevier Ltd.     
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Open access under the Elsevier OA license.ANP inhibits the proximal [11–13] and distal reabsorption of
ﬂuid [14,15], with cyclic guanosine monophosphate (cGMP) as a
second messenger [14]. In the rat proximal tubule, ANP inhibits the
sodium [16,17] and bicarbonate [18] reabsorption stimulated by
low doses of angiotensin II (ANG II). Studies in MDCK cells demon-
strated that ANP abolishes the stimulatory and inhibitory effects
of ANG II [19] or arginine vasopressin (AVP) [20] on the Na+/H+
exchanger and their stimulatory effects on [Ca2+]i. Taken together,
these data suggest that there may  be some interaction between
these vasoactive peptide hormones in the regulation of extracellu-
lar volume.
Given the recently described genomic and nongenomic actions
of ALDO in the mechanism of regulation of pHi and [Ca2+]i in the S3
segment [5] and considering that the physiological doses of ALDO
in blood are 10−10 to 10−9 M and that they can increase or decrease
in conditions of extracellular volume modiﬁcation, the objective of
the present study was  to examine the mechanism of interaction
between the nongenomic effects of ALDO (10−12 or 10−6 M,  2 min
preincubation) and ANP (10−6 M)  or BAPTA (5 × 10−5 M)  on the
NHE1 exchanger and [Ca2+]i in this portion of the proximal tubule
of rat kidneys.
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Table  1
Composition of solutions.
Solution 1 (control) Solution 2 (K+-HEPES) Solution 3 (NH4Cl) Solution 4 (0Na+e) Solution 5 (Tyrode’s)
NaCl 140 20 120 – 137
KH2PO4 2.5 – 2.5 2.5 –
CaCl2 1 1 1 1 1.36
MgSO4 1 1 1 1 –
MgCl2 – – – – 0.49
Glucose 5.5 – 5 5 5.6
l-Alanine 5 – 5 5 –
HEPES 10 5 10 10 5
NH4Cl – – 20 – –
NMDG –  – – 140 –
KCl  – 130 – – 2.68
NaHCO3 – – – – 12
Na2HPO4 – – – – 0.36
Nigericine – 0.01 – – –
pH  7.4 6.18; 7.14; 8.11 7.4 7.4 7.4
Values are expressed in mM.  NMDG, N-methyl-d-glucamine. HCl or NaOH were used in all Na+-containing solutions to titrate to the appropriate pH, and KOH was used in
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. Materials and methods
.1. Preparation of isolated S3 segment of rat
Male Wistar rats (90 g) were anesthetized by tile-
amine/zolazepam (30 mg/kg) and xylazine (2 mg/kg). Their
idneys were removed and slices 2 mm  in thickness were pre-
ared. Microdissection of the tubules was performed using
weezers under a stereomicroscope in ice-cold normal Ringer
olution. The S3 segments were dissected from the outer stripe
f the outer medulla [21,22] and were identiﬁed as the proximal
traight tubule contiguous to the thin descending limb of the
oop of Henle. Then, the S3 segments were transferred to glass
overslips prepared with poly-d-lysine for tubule adhesion. The
overslips were mounted on an inverted microscope (Olympus
X70) in a thermostatically regulated perfusion chamber with
olutions that were changed by means of valves.
.2. Viability of the tubules
After the experiments, the integrity of the S3 segments was
onﬁrmed by histological analysis and trypan blue exclusion. The
ubules were removed to trypan blue (0.4%) prepared in a buffered
sotonic salt solution (pH 7.4). This solution (0.1 ml)  was  added to
he bath for 3 min  at room temperature, and the color of the cell
ytoplasm of the tubules was observed [23].
.3. Measurement of pHi
For digital imaging of pHi, the S3 segments were incubated
n a HEPES-buffered solution with 140 mM Na+ (control solution,
able 1) containing 12 M BCECF-AM for 20 min  at 37 ◦C. The pHi
as calculated from the ﬂuorescence emission ratio collected every
 s with an intensiﬁed ICCD-350F camera during excitation at 440
nd 490 nm and emission at 530 nm.  The ﬂuorescence excitation
atio, I490/I440, was displayed in pseudo-color on the monitor, and a
aximum of 6 areas per tubule were deﬁned for measurement. The
Hi was standardized by the high K+/nigericin (solution 2, Table 1)
echnique [24].
.4. Cell pH recovery rateAfter superfusion of the S3 segments with control solution alone
o measure the basal pHi, the segment was induced to alkaliza-
ion by 2 min  of exposure to 20 mM NH4Cl solution (solution 3,Table 1) [25], followed by acidiﬁcation by the return to control
solution. The pHirr was measured in the presence of 140 mM exter-
nal Na+ (solution 1), in the absence of external Na+ (solution 4) or
in the presence of the following agents: 500 nM HOE 694 (a spe-
ciﬁc inhibitor of basolateral NHE1), 4.6 × 10−8 M concanamycin (a
H+-ATPase inhibitor), 10−12 or 10−6 M ALDO and/or 10 M spirono-
lactone (a MR  inhibitor), 10−6 M RU 486 (a GR inhibitor), 10−6 M
ANP or 5 × 10−5 M BAPTA (a calcium chelator). These drugs were
added to the bath at the same time as the acid pulse for a total
of 2 min  of preincubation. In all experiments, the pHirr (dpHi/dt,
pH units/min) was calculated in the ﬁrst 2 min  after the start of
the pHi recovery curve, by linear regression analysis. Calcula-
tions and graphical representations were performed by an Excel
program after importing the results from a data-acquisition pro-
gram.
2.5. Measurement of [Ca2+]i
The S3 segments were loaded for 15 min  with 10 (M of the
calcium-sensitive probe FLUO-4-AM [19] at 37 ◦C and rinsed in
Tyrode’s solution (solution 5). The FLUO-4 intensity emitted above
505 nm was  imaged using laser excitation at 488 nm on a Zeiss LSM
510 confocal microscope. The images were continuously acquired
(at time intervals of 2 s) before and after substitution of the experi-
mental solutions. The intracellular calibration was performed using
2.5 mM EGTA in a Ca2+-free bath and then in a 1.36 mM Ca2+ bath
containing ionomycin (5 M)  to measure the minimum (Fmin) and
the maximum (Fmax) cell calcium ﬂuorescent signals, respectively.
The standard equation [Ca2+]i = Kd ×(F − Fmin)/(Fmax − F) was used
to calculate the experimental values of [Ca2+]i [26], using the disso-
ciation constant (Kd) of 345 nM (according to the Molecular Probes
catalog).
2.6. Solutions and reagents
The solutions utilized had an osmolality of about
300 mOsmol/kg H2O and pH 7.4. BCECF-AM and FLUO-4-AM
were obtained from Molecular Probes (Eugene, OR, USA). The other
chemicals were purchased from Sigma Chemical Company (St.
Louis, MO,  USA).2.7. Statistics
The results are presented as means ± SEM. pHirr points are given
as N/n, where N is the number of superfused tubules, and n is the
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Fig. 1. Nongenomic dose-dependent biphasic effect of aldosterone (ALDO) on
Na+/H+ exchanger activity. (A) In the presence of 140 mM Na+ control solution, the
initial decrease in pHi is followed by a recovery of pHi toward the basal value. (B)
In  the presence of external control solution with 10−12 M ALDO, the pHi recovery
rate was increased. (C) In the presence of external Na+ control solution with 10−6 M
ALDO, the pHi recovery rate was decreased (and the ﬁnal pHi was  different from the
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Fig. 2. ANP inhibits the nongenomic biphasic effect of aldosterone (ALDO) on Na+/H+
exchanger. (A) In the presence of 10−6 M ANP alone, the pHi recovery rate was not
different from the control. (B) In the presence of ANP with 10−12 M ALDO, the pHi
recovery was not different from the control because ANP abolished the stimulatory
effect of 10−12 M ALDO on the velocity of pHi recovery. (C) In the presence of ANP
were ﬁrst bathed with control solution to exhibit the basal pHi. Dur-asal value).
umber of measured areas; the means were calculated from N, the
umber of tubules. [Ca2+]i points are given as N, where N is the
umber of tubules (each tubule is the average of 10 cell areas). Data
ere analyzed statistically by analysis of variance followed by the
onferroni’s contrast test. Differences were considered signiﬁcant
f P < 0.05.This study was approved by the Biomedical Sciences
nstitute/USP–Ethical Committee for Animal Research (CEEA).with 10−6 M ALDO, the pHi recovery also was not different from the control because
ANP abolished the inhibitory effect of 10−6 M ALDO on the velocity of pHi recovery.
3. Results
3.1. Intracellular pH
The results indicate that the S3 segment in the absence of bicar-
bonate and presence of 140 mM Na+ control solution has a mean
basal pHi of 7.15 ± 0.008 (16/96) (Table 2).
Fig. 1A shows a representative experiment in which S3 segmentsing the 2 min  exposure to NH4Cl, the pHi increased transiently, and
the removal of NH4Cl caused a rapid acidiﬁcation of pHi. Then, with
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Table  2
Summary of pHi measurements in presence of 140 mM external Na+ control solution alone or with HOE 694, 0 external Na+ solution alone or with Concanamycin, ALDO
and/or spironolactone, RU 486, ANP or BAPTA.
Basal pHi pHi acid load Final pHi dpHi/dt (pH units/min) N/n
Control 7.15 ± 0.008 6.55 ± 0.084 7.12 ± 0.045 0.195 ± 0.012 16/96
HOE  500 nM 7.03 ± 0.018 6.22 ± 0.125 6,16 ± 0.169a −0.042 ± 0.018a 5/27
0  Na+e 7.12 ± 0.020 6.0 ± 0.058 6,40 ± 0.068a 0.068 ± 0.008a 8/27
0  Na+e + Concanamicyn 4.6 × 10−8 M 7.06 ± 0.033 6.23 ± 0.038 6,15 ± 0.050a −0.020 ± 0.014a,b 5/25
ALDO  10−12 M 7.11 ± 0.011 6.36 ± 0.059 7.12 ± 0.058 0.310 ± 0.026a 6/24
ALDO  10−6 M 7.12 ± 0.019 6.58 ± 0.074 6.89 ± 0.087a 0.096 ± 0.009a 5/18
Spironolactone 10 M 7.08 ± 0.022 6.67 ± 0.046 7.02 ± 0.036 0.192 ± 0.006 6/30
Spironolactone + ALDO 10−12 M 7.07 ± 0.017 6.33 ± 0.044 7.07 ± 0.014 0.296 ± 0.008a 5/15
Spironolactone + ALDO 10−6 M 7.07 ± 0.012 6.10 ± 0.045 6.41 ± 0.029a 0.090 ± 0.005a 5/24
RU  486 10−6 M 7.06 ± 0.010 6.11 ± 0.036 6.54 ± 0.031a 0.118 ± 0.002a 6/31
RU  486 + ALDO 10−12 M 7.04 ± 0.015 6.31 ± 0.019 7.03 ± 0.014a 0.197 ± 0.008a,b 6/25
RU  486 + ALDO 10−6 M 7.08 ± 0.008 6.19 ± 0.040 6.59 ± 0.035 0.126 ± 0.003d 6/24
ANP  10−6 M 7.14 ± 0.034 6.40 ± 0.192 7.02 ± 0.143 0.218 ± 0.012 5/23
ANP  + ALDO 10−12 M 7.13 ± 0.010 6.80 ± 0.114 7.31 ± 0.088 0.20 ± 0.027c 5/15
ANP  + ALDO 10−6 M 7.11 ± 0.012 6.61 ± 0.125 7.11 ± 0.086 0.211 ± 0.022d 7/25
BAPTA  5 × 10−5 M 7.13 ± 0.039 6.40 ± 0.072 7.11 ± 0.039 0.214 ± 0.015 6/16
BAPTA  + ALDO 10−12 M 7.05 ± 0.007 6.47 ± 0.054 7.03 ± 0.008 0.216 ± 0.009c 7/26
BAPTA  + ALDO 10−6 M 7.08 ± 0.019 6.36 ± 0.082 7.06 ± 0.021 0.191 ± 0.012d 6/16
Values are means ± SE; N/n is the number of tubules/number of areas.
a P < 0.03 vs. respective control.
b P < 0.001 vs. 0Na+e.
c −12
t
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HP < 0.02 vs. Aldo 10 M.
d P < 0.008 vs. Aldo 10−6 M.
he return of external control solution, this fall in pHi was  imme-
iately followed by a recovery toward the basal value. According
o results previously published by our laboratory in isolated rat
roximal S3 segments, this recovery of pHi occurs mainly via the
a+/H+ exchanger [5]. Fig. 1B indicates that the addition of ALDO
t 10−12 M to the bath increased the pHirr. However, Fig. 1C shows
ig. 3. Mean values of intracellular pH recovery rate after acid load. The intracellular pH re
OE  694 or 0 external Na+ solution alone or with concanamycin. N/n = number of tubulesthat the addition of ALDO at 10−6 M decreased the pHirr, and pHi
recovery was  not complete.Fig. 2A shows a representative experiment to indicate that with
ANP (10−6 M)  alone, the pHirr and the ﬁnal pHi were not different
from the control value. However, Fig. 2B and C shows that ANP
impaired both the stimulatory and inhibitory effects of ALDO on
covery rate was evaluated in the presence of 140 mM external Na+ control solution,
/number of areas. *P < 0.001 vs. respective control.
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ith  spironolactone (10 M),  RU 486 (10−6 M),  ANP (10−6 M) or BAPTA (5 × 10−5 M
espective control and 10−12 M ALDO. #P < 0.02 vs. 10−12 M ALDO. ∝P < 0.008 vs. 10−
he pHirr (and during both situations, the ﬁnal pHi was  not different
rom the basal value).
Fig. 3 shows that in the control situation (140 mM Na+e) the
ean pHirr was 0.195 ± 0.012 pH units/min (16/96), and the super-
usion of tubules with HOE 694 alone inhibited the pHirr, indicating
hat the pHirr is mostly due to the basolateral NHE1 in S3 segments.
n addition, Fig. 3 shows that in the absence of Na+e (a condition
hat inhibits the activity of Na+/H+ exchanger), there was a signiﬁ-
antly lower pHirr, indicating that a Na+-independent H+ extrusion
echanism exists in the S3 segment of normal rats. This small
Hirr was abolished by concanamycin, showing that the H+-ATPase
s the only mechanism responsible for this Na+-independent H+
ransport. However, this mechanism of cellular extrusion of H+
nitiates about 2.5 min  after cellular acidiﬁcation with the NH4Cl
ulse.
Fig. 4 indicates that 10−12 M ALDO increased the pHirr by
pproximately 59% of the control value, and 10−6 M ALDO
ecreased it by approximately 49% of the control value. Spirono-
actone alone did not alter the pHirr and did not prevent the
timulatory and the inhibitory effects of ALDO on the Na+/H+
xchanger, demonstrating that this rapid biphasic effect of ALDO
s independent of binding with the MR  receptor. RU 486 alone
ecreased the pHirr (approximately 39% of control value); in addi-
ion, RU 486 abolished the stimulatory effect of ALDO but did not
lter its inhibitory effect on the Na+/H+ exchanger. These results
uggest that the GR antagonism interferes with the nongenomic
timulatory effect of ALDO on the Na+/H+ exchanger. Fig. 4 also
hows that, compared to the control, ANP or BAPTA alone did not
igniﬁcantly alter the pHirr; however, ANP or BAPTA signiﬁcantlypH recovery rate was evaluated in the presence of ALDO (10−12 or 10−6 M) alone or
 = number of tubules/number of areas. *P < 0.005 vs. respective control. ‡P < 0.02 vs.
DO.
abolished both stimulatory and inhibitory effects of ALDO on the
pHirr.
Table 2 summarizes the mean values of pHi and pHirr responses
found in all experimental groups studied.
3.2. Cytosolic calcium
Fig. 5 gives the cell calcium ﬂuorescent signal tracing during
3 min  in one representative experiment from each of 6 experi-
mental groups. The images were continuously acquired (at time
intervals of 2 s) before and after the addition of different drug
solutions to the bath. The baseline value did not signiﬁcantly
change. However, approximately 0.4 min  after the addition of ALDO
(10−12 M or 10−6 M),  there was a transient (approximately 1.5 min)
and dose-dependent increase of the ﬂuorescent signal, followed by
a recovery toward the basal value. The addition of ANP (10−6 M)
alone to the bath led to a rapid decrease of the ﬂuorescent signal
and prevented the dose-dependent stimulatory effect of aldos-
terone.
Fig. 6 and Table 3 show that the S3 segment exhibited a
mean baseline [Ca2+]i of 104 ± 3 nM (15). ALDO, at a concentra-
tion of 10−12 or 10−6 M,  caused an increase of this parameter
to approximately 50% or 124% of the control value, respectively.
Spironolactone (10 M)  alone did not change the basal value of
the [Ca2+]i or the stimulatory effect of either dose of ALDO on the
[Ca2+]i. RU 486 (10−6 M),  ANP (10−6 M)  and BAPTA (5 × 10−5 M)
decreased the [Ca2+]i to approximately 31%, 44% and 52% of the
basal value, respectively. ANP and BAPTA also decreased the stim-
ulatory effect of ALDO (10−12 or 10−6 M)  on the [Ca2+]i; however, RU
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86 completely prevented the stimulatory effect of 10−12 M ALDO
nd reversed the stimulatory effect of 10−6 M ALDO to an inhibitory
ffect.The histological analysis, performed after the measurement of
Hirr or [Ca2+]i, revealed normal tubular structures with complete
ubical cells and a brush-border membrane typical of proximal
able 3
eans values of cytosolic calcium concentration in presence of control solution,
LDO and/or Spironolactone, RU 486, ANP or BAPTA.
Experimental groups [Ca2+]i (nM) N
Control 104 ± 3 15
ALDO 10−12 M 156 ± 9a 5
ALDO 10−6 M 233 ± 9a 5
Spironolactone 10 M 99 ± 5 5
Spironolactone + ALDO 10−12 M 166 ± 2a 5
Spironolactone + ALDO 10−6 M 235 ± 7a 5
RU  486 10−6 M 72 ± 1a 5
RU  486 + ALDO 10−12 M 100 ± 2b 5
RU  486 + ALDO 10−6 M 74 ± 1c 5
ANP  10−6 M 58 ± 2a 10
ANP  + ALDO 10−12 M 80 ± 3b 5
ANP  + ALDO 10−6 M 113 ± 7d 5
BAPTA 5 ×10−5M 50 ± 2a 5
BAPTA + ALDO 10−12 M 78 ± 3b 5
BAPTA + ALDO 10−6 M 113 ± 1d 5
alues are means ± SE. N is the number of tubules (each tubule is the average of 10
ell  areas).
a P < 0.0001 vs. respective control.
b P < 0.0005 vs. respective control and ALDO 10−12 M.
c P < 0.0001 vs. ALDO 10−6 M.
d P < 0.0001 vs. respective control and ALDO 10−6 M. were continuously acquired in the presence of control solution or before and after
tubules. The tubules with up to 1 h pi at 37 ◦C showed no change in
cytoplasmic staining, indicating the maintenance of cell membrane
integrity after pHirr or [Ca2+]i measurements.
4. Discussion
The purpose of this study was  to clarify the mechanism of inter-
action between the nongenomic effects (2 min preincubation) of
ALDO and/or ANP on Na+/H+ exchanger and on [Ca2+]i in isolated
proximal S3 segment of rats. This is a region of the nephron where
the mechanisms of tubular ion transport are less studied because
it is located in the outer stripe of the outer medulla, a region difﬁ-
cult to access in general and impossible to access directly by in vivo
micropuncture.
Our results indicate that in the S3 segment, the pHi recovery
mostly occurs via the Na+/H+ exchanger, because the superfusion of
the tubules with HOE 694 (a speciﬁc inhibitor of basolateral NHE1)
promotes the complete inhibition of pHirr. These results are in
accordance with previous data published by our laboratory [5].  Our
results also indicate that during the superfusion of the S3 segment
with a zero Na+ solution (which inhibits the activity of the Na+/H+
exchanger), a small pHirr still was observed, which was abolished
by concanamycin (a H+-ATPase inhibitor); these data agree with
recently published results [27] showing that in the S3 segment the
pHi recovery also occurs via H+-ATPase. However, in our present
study and recently published work [27], the activity of this trans-
porter begins about 2.5 min  after the acid pulse and does not reach
the basal pHi. Thus, this mechanism of cellular extrusion of H+ does
not interfere with the present evaluation of pHirr dependent on the
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nd/or spironolactone (10 M),  RU 486 (10−6 M),  ANP (10−6 M) or BAPTA (5 × 10−
espective control. #P < 0.0005 vs. respective control and 10−12 M ALDO. †P < 0.0001
a+/H+ exchanger (because it is calculated within the ﬁrst 2 min
fter cellular acidiﬁcation).
In theory, NHE1 is expressed in the basolateral membrane of
ll segments of the renal tubule, where it is involved with cyto-
lasmic pH and volume regulation, and is considered an important
arget of ALDO nongenomic actions [28,29]. In our present stud-
es, we observed a rapid effect of ALDO on NHE1. Similar results
ere reported by other authors [7,8,30–32],  who propose that such
ffects occur through a nongenomic pathway. Our previous exper-
ments [5],  also in the S3 segment of rats, showed that the effects of
LDO (with 2 or 15 min  of preincubation) on the NHE1 exchanger
soform occur through a nongenomic pathway because they were
nsensitive to actinomycin (an inhibitor of gene transcription),
ycloheximide (an inhibitor of protein synthesis) and spironolac-
one (a mineralocorticoid receptor (MR) antagonist). Markos et al.
8] demonstrated that ALDO causes a rapid nongenomic increase in
HE1 activity in M-1  cortical collecting duct cells via the PKC/MAPK
athway; they also found that this effect is independent of MR.
ekle et al. [30] also veriﬁed a rapid activation of NHE1 in MDCK
ells after approximately 5 min  of exposure to ALDO.
The present results indicate that the lowest dose of ALDO
10−12 M)  increases the speed of H+ extrusion and, therefore,
timulates the NHE1 exchanger; on the other hand, the higher
ose of ALDO (10−6 M)  decreases the speed of H+ extrusion and,
herefore, inhibits this transporter, showing once again the dose-
ependent biphasic effect of ALDO in NHE1. The receptor involved
n the rapid responses of ALDO in non-polarized and polarized
ells, including renal epithelial cells, is still unknown. However,tration was evaluated in the presence of control solution, ALDO (10−12 or 10−6 M)
N = number of tubules (each tubule is the average of 10 cell areas). *P < 0.0001 vs.
−6 M ALDO. ∝P < 0.0001 vs. control and 10−6 M ALDO.
in an attempt to identify the receptor of the nongenomic effect
of ALDO on NHE1 in the S3 segment, we studied the action
of spironolactone (a MR  antagonist) and RU 486 (a GR antago-
nist) on the pHirr and [Ca2+]i, in the presence and absence of
ALDO. Spironolactone alone did not alter the pHirr or the [Ca2+]i
and failed to prevent the short-term effects of ALDO (10−12 and
10−6 M)  on these parameters. Consistent with our results, some
studies showed nongenomic spironolactone–insensitive effects of
aldosterone in vascular smooth muscle cells [33], in renal epithe-
lial cells [7,8,34,35],  in the glomerular microcirculation [36] and
in medullary thick ascending limb [10]; whereas the present
results demonstrated this effect in proximal tubule. RU 486 alone
decreased the pHirr and [Ca2+]i, prevented the stimulatory effect
of ALDO (10−12 M)  on both parameters, maintained the inhibitory
effect of ALDO (10−6 M)  on pHirr and reversed the stimulatory effect
of ALDO (10−6 M)  on [Ca2+]i to an inhibitory effect. Considering
these results and the fact that the nongenomic ALDO action on the
proximal NHE1 and NHE3 isoforms is sensitive to GR antagonism
[2,5] and that GR is much more abundant than the MR  in the proxi-
mal  tubule [37], it is plausible to suggest that GR participates in the
nongenomic effect of ALDO in the present experiments.Our present
results show that ANP alone has no effect on the Na+/H+ exchanger;
this behavior is in agreement with our data showing that, in MDCK
cells, ANP (10−6 M)  does not affect this exchanger [19]. However,
in rat aortic smooth muscle (RASM) cells, 10−10 M ANP activates
the Na+/H+ exchanger and 10−7 M ANP inhibits it [38]; in addition,
in the ocular nonpigmented ciliary epithelium (NPE) cells, 10−7 M
ANP has an inhibitory effect on the Na+/H+ exchanger activity [39].
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 possible explanation for these different results would be that the
irect effect of ANP on Na+/H+ exchanger depends on the cell type.
However, the present study is the ﬁrst demonstration, to our
nowledge, that ANP inhibits the nongenomic biphasic effect of
LDO on NHE1 in proximal S3 segment of rat. This action was
emonstrated by prevention of the change in pHirr when the S3
egment was superfused with ANP and ALDO (10−12 or 10−6 M).
herefore, our data are in accordance with the studies in the rat
roximal convoluted tubule showing that ANP inhibits the bicar-
onate [18] and sodium [16,17] reabsorption stimulated by low
oses of ANG II and with the experiments in MDCK cells demon-
trating that ANP abolishes the stimulatory and inhibitory effects
f ANG II [19] or AVP [20], despite the lack of effect of ANP alone
n proximal convoluted tubule and MDCK cells.
To obtain more information about the nongenomic mechanism
f interaction of ANP and ALDO on the modulation of pHi in the
3 segment, we also studied the effects of ANP with ALDO (2 min
reincubation) on the regulation of [Ca2+]i. The present data indi-
ate that the baseline [Ca2+]i was 104 ± 3 nM (15) and that after
ddition of ALDO (10−12 or 10−6 M)  to the bath, there was  a rapid
approximately 0.4 min) dose-dependent increase of the [Ca2+]i.
ekle et al. [7] demonstrated that the elevation of [Ca2+]i partic-
pates in the fast activation of ALDO on the Na+/H+ exchanger in
enal epithelial cells, and our current results indicate that the rapid
nd biphasic aldosterone-induced effect on Na+/H+ exchanger is
robably associated with the increase of [Ca2+]i.
Some studies [19,40] have found that the NHE1 exchanger
as two calmodulin binding sites at the cytoplasmic regulatory
omain that modulate its activity. A high-afﬁnity site, which is
onically inhibitory, binds to low Ca2+/calmodulin levels, thus sup-
ressing the inhibition (i.e., stimulating the exchanger at low
a2+/calmodulin levels). A low afﬁnity site, however, binds to Ca2+
nd calmodulin only at high concentrations and, under these condi-
ions, inhibits the exchanger activity. More recently, we  modiﬁed
mino acids in these two  binding sites of NHE1 by site-directed
utagenesis and obtain data that reinforce this idea [41]. This
ehavior is compatible with our present ﬁndings, indicating stim-
lation of the NHE1 exchanger by increases of [Ca2+]i in the lower
ange (at 10−12 M ALDO) and inhibition of this exchanger at high
Ca2+]i levels (at 10−6 M ALDO). The results using RU 486 also agree
ith this NHE1 regulation by alterations in the [Ca2+]i, because this
R antagonist alone or with ALDO (10−12 or 10−6 M)  decreased the
Ca2+]i, abolishing the stimulatory effect of ALDO (10−12 M)  and
aintaining the inhibitory effect of ALDO (10−6 M)  on the pHirr.
Several actions of ANP depend on its interaction with type B
eceptors, coupled to the activation of guanylyl cyclase in the mem-
rane that leads to increased levels of cGMP from GTP [14,42].
he elevation of cGMP may  inhibit the activity of phospholipase
 or stimulate the Ca2+-ATPase of the sarcoplasmic reticulum, with
he consequent reduction of [Ca2+]i [43]. Our present results show
hat the addition of ANP alone to the bath decreases the [Ca2+]i
o approximately 44% of the control value. In the presence of ANP
ith ALDO (10−12 or 10−6 M),  there is a dose-dependent recovery of
Ca2+]i, but the [Ca2+]i does not reach ALDO (10−12 or 10−6 M)  alone
alues. These ﬁndings are consistent with our results concerning
he effect of this hormone on the pHirr. ANP alone does not affect
he pHirr because it only causes a moderate decrease in [Ca2+]i. On
he other hand, ANP impairs both the stimulatory and inhibitory
ffects of ALDO on the pHirr because it impairs the increase in
Ca2+]i in response to ALDO, thus modulating the nongenomic cel-
ular action of ALDO. The effect of this hormonal interaction on the
Hirr and on [Ca2+]i is similar to the rapid effect we  observed with
NP with ANG II [19] or AVP [20] in MDCK cells.
In the present experiments, BAPTA, an intracellular calcium
helator, was used to conﬁrm the effects of the decrease on [Ca2+]i
n NHE1 activity. BAPTA (5 × 10−5 M)  alone or with ALDO (10−12 oristry & Molecular Biology 128 (2012) 89– 97
10−6 M)  decreased the [Ca2+]i by approximately 50% and blocked
both the stimulatory and inhibitory effects of ALDO on NHE1 activ-
ity. These results are in accordance with a recent study, also in the
S3 segment, wherein BAPTA prevented the increase of [Ca2+]i and
the H+-ATPase activity in response to ALDO [27].
5. Conclusions
Our current studies in the isolated proximal straight tubule sug-
gest a role for [Ca2+]i in regulating the process of pHi recovery after
the acid load induced by NH4Cl, which is mediated by the baso-
lateral NHE1 exchanger and stimulated/impaired by ALDO via a
nongenomic pathway. The results are compatible with stimula-
tion of the NHE1 exchanger by increases in [Ca2+]i in the lower
range (at 10−12 M ALDO) and inhibition at high [Ca2+]i levels (at
10−6 M ALDO). This ﬁnding is also compatible with the identiﬁca-
tion of two sites on the COOH terminus of the NHE1 exchanger:
one that stimulates the exchanger activity at low [Ca2+]i levels,
and one that inhibits this activity at high [Ca2+]i. ANP and BAPTA
decrease [Ca2+]i to approximately 45–50% of the control value and
do not affect the pHi recovery, but these compounds impair the
increase in [Ca2+]i and block both the stimulatory and inhibitory
effects of ALDO on this process. RU 486, but not spironolactone,
interferes with the increase of [Ca2+]i and the nongenomic effect
of ALDO on NHE1, suggesting that the GR could participate in this
mechanism. Although we have shown evidence for the importance
of [Ca2+]i, it is possible that signaling mechanisms besides [Ca2+]i
contribute to the nongenomic action of ALDO on NHE1 exchanger.
The observed nongenomic hormonal interaction in the proximal
straight tubule (a less studied proximal tubular portion) may  rep-
resent a mechanism for the rapid and physiologically relevant
regulation in conditions of volume depletion or expansion in the
intact animal.
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